<html>
<head>PUBMED IDs for CKS1B</head>
<body bgcolor='#C5F0F2'><h1>CKS1B</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15520179/'>From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies.</a> November 3  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15576476/'>High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma.</a> December 4  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16149245/'>[Molecular genetic methods for the prognostic criteria in multiple myeloma].</a> September 10  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16149221/'>[The molecular screening of the stool for the colorectal carcinoma].</a> September 10  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16188652/'>Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma.</a> September 29  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16399589/'>Using genomics to identify high-risk myeloma after autologous stem cell transplantation.</a> January 10  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16889615/'>Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation.</a> August 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16889612/'>Relationships between the adverse effects of drugs and genetic polymorphism in genes encoding drug metabolizing enzymes.</a> August 8  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16996589/'>Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma.</a> September 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16995883/'>Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation.</a> September 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17024118/'>Prognostic value of chromosome 1q21 gain by fluorescent in situ hybridization and increase CKS1B expression in myeloma.</a> October 7  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17303695/'>CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.</a> February 17  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17478923/'>Gene expression profiling defines a high-risk entity of multiple myeloma.</a> May 5  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17854306/'>Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myeloma.</a> September 15  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19448682/'>1p21 deletions are strongly associated with 1q21 gains and are an independent adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.</a> March 24  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20421271/'>CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma.</a> November 9  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20465575/'>In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.</a> January 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20676120/'>Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.</a> January 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20737481/'>CKS1B amplification is a frequent event in cutaneous squamous cell carcinoma with aggressive clinical behaviour.</a> January 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20930946/'>Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.</a> May 20  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20930934/'>Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.</a> February 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21042722/'>Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells.</a> February 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21117028/'>CDC28 protein kinase regulatory subunit 1B (CKS1B) expression and genetic status analysis in oral squamous cell carcinoma.</a> March 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22528125/'>Tissue-specific transplantation antigen P35B (TSTA3) immune response-mediated metabolism coupling cell cycle to postreplication repair network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by biocomputation.</a> September 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22548738/'>Proposed megakaryocytic regulon of p53: the genes engaged to control cell cycle and apoptosis during megakaryocytic differentiation.</a> October 2  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22548731/'>Association of ATP binding cassette transporter G8 rs4148217 SNP and serum lipid levels in Mulao and Han nationalities.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23879533/'>Overexpression of CDC28 protein kinase regulatory subunit 1B confers an independent prognostic factor in nasopharyngeal carcinoma.</a> April 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24169086/'>Genomic aberrations in anaplastic multiple myeloma: high frequency of 1q21(CKS1B) amplifications.</a> February 19  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24205826/'>Identification of novel human kinases that suppress hepatitis C virus infection.</a> October 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24205801/'>Helicobacter pylori antigen HP0986 (TieA) interacts with cultured gastric epithelial cells and induces IL8 secretion via NF-κB mediated pathway.</a> July 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24303203/'>Cancer specificity of promoters of the genes involved in cell proliferation control.</a> December 5  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24913506/'>Neoplastic plasma cell aberrant antigen expression patterns and their association with genetic abnormalities.</a> April 6  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24973170/'>Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders.</a> March 31  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25187488/'>Cancer specificity of promoters of the genes controlling cell proliferation.</a> August 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25477524/'>Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells.</a> April 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25597412/'>The clinical relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 network in chemoresistant non-small-cell lung cancer.</a> April 6  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25995187/'>Hypoxia drives transient site-specific copy gain and drug-resistant gene expression.</a> July 22  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26755726/'>Regulation of Transient Site-specific Copy Gain by MicroRNA.</a> August 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27558135/'>A Synthetic Dosage Lethal Genetic Interaction Between CKS1B and PLK1 Is Conserved in Yeast and Human Cancer Cells.</a> August 26  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28439706/'>CKS1BP7, a Pseudogene of CKS1B, is Co-Amplified with IGF1R in Breast Cancers.</a> April 26  2017<br></body></html>
